Intellectual Property

  • October 27, 2026

    Bic Sues California Shops Over Counterfeit Lighters

    Bic Corp. has filed several suits against wholesalers, gas stations, vape shops and other retailers in California federal court, alleging they've been selling counterfeit lighters that use Bic's designs and logos.

  • October 26, 2026

    Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit

    A New Jersey federal judge on Monday refused to issue an injunction blocking Eli Lilly & Co. from running ads allegedly comparing its GLP-1 drug to Novo Nordisk Inc.'s using "outdated" clinical trials and "false superiority messages," ruling that Novo Nordisk hasn't shown it would be irreparably harmed.

  • October 26, 2026

    Salsa Producer Had Rights To 3 Albums, Jury Finds

    A federal jury in Miami came back with a mixed verdict Friday in a dispute between a Venezuelan salsa composer and his former business partner and producer, finding the producer had a valid license for three of the six albums at issue and owned one of two trademarks.

  • October 26, 2026

    Data-Scraping Co. Says Reddit Must Face Counterclaims

    A data-scraping company accused of acting like "would-be bank robbers" in taking in copyrighted data from Reddit that is then used to train AI said in a brief defending its antitrust counterclaims that the content in question actually belongs to Reddit users, and that Reddit anticompetitively restricts access to it.

  • October 26, 2026

    Blue Cross Says National TM Link Dooms Ford Antitrust Suit

    Blue Cross Blue Shield of Michigan and the Blue Cross Blue Shield Association have asked a Michigan federal judge to hand them a win in Ford Motor's antitrust suit alleging supracompetitive pricing, arguing the Blue Cross trademark means the association and affiliates act as a "single entity" that "cannot conspire with itself."

  • October 26, 2026

    Soul BnB Says Airbnb Didn't Properly Serve TM Case

    A wellness retreat company called Soul BnB asked a California federal judge on Monday to lift a default judgment in a trademark infringement lawsuit filed by Airbnb, claiming the suit was not properly served.

  • October 26, 2026

    LA Producer Sues Tony Robbins, Fox Over 'Man's Search' Film

    A Los Angeles producer has sued Tony Robbins, Fox Corp., her former business partner and multiple other entities in California federal court, alleging they engaged in "disloyalty, concealment and self-dealing" and iced her out of adapting Holocaust survivor Viktor Frankl's best-selling memoir "Man's Search for Meaning" into a feature-length film.

  • October 26, 2026

    Dugout Divided: Foley & Lardner Clients Clash In World Series

    The World Series matchup between Foley & Lardner LLP clients, the Milwaukee Brewers and the Tampa Bay Rays, has pitted partners against one another as the firm enjoys a good-natured intrasquad rivalry during the Fall Classic.

  • October 26, 2026

    Squires Explains Why He Granted IPR Of Whirlpool Patent

    U.S. Patent and Trademark Office Director John Squires said that Samsung was able to show that part of a Whirlpool dishwasher utensil caddy patent is found in an earlier patent application.

  • October 26, 2026

    Neil Young Sues Trump Committee Over Rally Song

    Singer-songwriter Neil Young sued President Donald Trump's joint fundraising committee for $10 million in Virginia federal court Monday, claiming that the committee violated a 2020 settlement when it used his hit "Rockin' in the Free World" without a license at an Ohio rally earlier this month.

  • October 26, 2026

    Apple, Microsoft Accused Of Infringing Cybersecurity Patents

    Tech giants Apple Inc. and Microsoft have each been sued in Texas federal court by a cybersecurity firm with claims of infringing two patents that cover the detection of memory corruption.

  • October 26, 2026

    Bristol-Myers, Others Appeal Revlimid MDL To 3rd Circ.

    Bristol-Myers Squibb, Natco Pharma, AbbVie and other pharmaceutical companies have sought permission to file an interlocutory appeal for a sprawling antitrust multidistrict litigation over Celgene Corp.'s cancer drug Revlimid to the Third Circuit after a New Jersey federal judge refused to toss it.

  • October 26, 2026

    Hewlett Packard Hits Exec With AI Trade Secret Suit

    Hewlett Packard Enterprise says in a Colorado federal court suit that an executive it has placed on administrative leave is improperly in possession of trade secrets covering an artificial intelligence tool he oversaw the development of.

  • October 26, 2026

    Sterlington Nabs 9-Member Patent Team From Holland & Hart

    Sterlington PLLC has hired a nine-member patent team led by two former Holland & Hart LLP partners, the firm announced Monday.

  • October 26, 2026

    Anthropic Pilfered Elvis Presley Songs To Train AI, Suit Says

    Owners of copyrights in 274 songs recorded by Elvis Presley have sued Anthropic for nearly $50 million, alleging the artificial intelligence company used their lyrics for training data, stripped identifying information and enabled its chatbot Claude to generate infringing material.

  • October 26, 2026

    USPTO Chief Says China Ties Sink Fastener Patent Challenge

    The head of the U.S. Patent and Trademark Office said a patent challenger's ties to the Chinese government were the reason he had shot down a petition that sought to invalidate a Howmet Aerospace patent on a type of fastener.

  • October 23, 2026

    Teva, Eli Lilly Spar Over Possible New Drug Patent Trial

    Eli Lilly and Teva on Friday sparred over whether a new trial should be held in Massachusetts federal court over the validity of patents related to Teva's migraine drug Ajovy after the Federal Circuit reversed the Boston court's judgment that favored Eli Lilly.

  • October 23, 2026

    Fortinet Sued Over Cybersecurity Technology In EDTX

    Long Horizon Technologies LLC has accused cybersecurity company Fortinet Inc. of infringing a patent directed to installing embedded firmware.

  • October 23, 2026

    Dutch Software Co. Seeks To Unravel $400K Contempt Order

    A Dutch software company is looking to undo a $400,000 sanctions order against it in a long-running trademark battle with its former U.S. partner, saying there is no evidence of harm to the opposing party sufficient to support the court's contempt ruling.

  • October 23, 2026

    Del. Forum Selection Clause Sinks IQVIA's NC Poaching Suit

    IQVIA Holdings Inc. should have brought its poaching suit against four former employees accused of defecting to a competitor in Delaware court under a forum selection clause in their employment contracts, a North Carolina Business Court judge ruled Thursday in dismissing the case.

  • October 23, 2026

    Alembic Settles With Vanda Over Schizophrenia Drug Generic

    Vanda Pharmaceuticals and Alembic Pharmaceuticals notified a Delaware federal judge Friday that they have settled a patent dispute over Alembic's planned generic version of Vanda's schizophrenia drug Fanapt.

  • October 23, 2026

    Insulet Can't Keep Injunction During Trade Secret Appeal

    The Federal Circuit has denied insulin product developer Insulet Corp.'s request to keep an injunction in place against rival EOFlow Co. Ltd. while it appeals an axed $59 million trade secrets jury verdict to the U.S. Supreme Court.

  • October 23, 2026

    Startups, Inventors Urge High Court To Review $2.6B IP Case

    The Alliance of U.S. Startups & Inventors for Jobs has called for the U.S. Supreme Court to take up Centripetal Networks LLC's petition arguing a $2.6 billion infringement victory against Cisco was taken away without due process, with the organization warning the holding will disincentivize innovation by smaller companies and individuals.

  • October 23, 2026

    Copyright Ruling Leaves Worldwide Rights In Legal Limbo

    The U.S. Supreme Court left music publishers, creators and catalog buyers facing potentially different rules for worldwide copyright termination after an unusual quorum failure ended the entertainment industry's bid to overturn a Fifth Circuit ruling allowing authors to recapture foreign rights included in worldwide grants.

  • October 23, 2026

    AI Cardiac Imaging Co. Heartflow Files IP Suit Against Rival

    Artificial intelligence-powered cardiac imaging company Heartflow Inc. is accusing a competitor of infringing its patents covering a noninvasive heart test and luring almost a dozen of its employees to make a similar product.

Expert Analysis

  • 4 Opinions Showcase Hurdles To Trademarking Names

    Author Photo

    Four opinions issued by the Trademark Trial and Appeal Board this year show that names are only registrable as trademarks when they point to the applicant and to nobody else, says Anton Hopen at Trenam Law.

  • Reel Justice: 'The Furious' And Journalistic Evidence

    Author Photo

    Viewing "The Furious” from a litigator’s perspective highlights nuances that arise when gathering evidence from journalistic investigations, serving as a reminder to not only ask whether evidence is relevant, but also what legal framework governs the person or entity holding it, says Veronica Finkelstein at Widener-Delaware Law.

  • 'Demon Hunter' IP Suit Highlights Reverse Confusion Perils

    Author Photo

    A metal band named Demon Hunter's recently filed lawsuit against Netflix, alleging that consumers mistakenly believe it to be connected to the "KPop Demon Hunters" movie, provides a useful vehicle for examining the reverse confusion doctrine and its practical implications, say attorneys at Troutman Pepper.

  • 5th Circ. Embedding Decision Could Recast Copyright Claims

    Author Photo

    The Fifth Circuit's decision in Emmerich v. Particle Media addresses decades of ambiguity surrounding whether embedded content can constitute copyright infringement, potentially affecting how defense counsel fight against such claims, say attorneys at Greenberg Glusker.

  • Resetting For Success After Corporate Litigation Loses Focus

    Author Photo

    Corporate litigation that has lost strategic coherence may barrel disastrously ahead if counsel’s understanding of the matter drifts from the client’s goals, but cases can be wrenched back on track by diagnosing how facts have evolved, determining where resources are justified and deploying practical strategies for restoring discipline, says Jonathan Morris at Gordon Rees.

  • How Bifurcation And Verdict Forms Can Sway Jury Outcomes

    Author Photo

    The bifurcated trial structure used in a Nevada personal injury case — where the jury recently awarded the plaintiff more than $56 million — highlights a strategic option that litigators often overlook and raises considerations about the potential advantage of carefully assembled verdict forms, says litigation consultant Clint Townson.

  • Opinion

    Fed. Circ. Should Redefine Functionality In Design Patents

    Author Photo

    The Federal Circuit should establish a framework for identifying the relevant article of manufacture to which functionality analysis applies, in order to enhance doctrinal clarity and better reflect the statutory foundations of design patent law, say attorneys at Knobbe Martens.

  • Where AI Patent Risk Begins And How Records Can Help

    Author Photo

    The Federal Circuit's recent decision in Dental Monitoring v. Align highlights the importance of documenting how artificial intelligence-assisted inventions work, and how humans contributed, as such records can support inventorship, written description, eligibility and definiteness requirements, say attorneys at Sterne Kessler.

  • 2nd Circ. Tylenol MDL Ruling Clarifies Court Gatekeeper Role

    Author Photo

    The Second Circuit’s recent decision in multidistrict litigation over alleged links between Tylenol and developmental disorders, holding that the trial court improperly excluded expert witnesses, preserves meaningful judicial gatekeeping while making clear that judges may not resolve legitimate scientific disputes themselves, say attorneys at Lowenstein Sandler.

  • Series

    Law School's Missed Lessons: Cultivating Good Judgment

    Author Photo

    Law schools generally overlook the role that solid judgment skills play in real-world practice, but attorneys can bridge the gap by strengthening their abilities to assess a case’s strengths and weaknesses, develop and execute effective strategies, and provide clear recommendations to clients, says Manny Caixeiro at Venable.

  • What To Expect From Colorado's New Artist Co. Structure

    Author Photo

    Colorado's newly established class of artist companies, or A-Corps, provides a useful structure for small-scale ventures, but challenges could arise for more complex business plans, and limitations on investor participation may limit widespread adoption, say attorneys at Armstrong Teasdale.

  • 9th Circ. Comet Ruling Spotlights Trade Secret Proof Burdens

    Author Photo

    The Ninth Circuit’s recent decision to vacate a $40 million verdict awarded to Comet Technologies in its trade secret dispute with XP Power underscores how the burden of proof differs between federal and state law, giving litigants a fresh perspective on several issues, including how a jury should be instructed, say attorneys at Cooley.

  • What Trial Teams Should Know About AI Jury Research Tools

    Author Photo

    Using artificial intelligence for jury research is quickly becoming part of the litigation consulting landscape, and can be a useful part of a case assessment toolkit — but litigators must understand what these systems are built to measure, and what conclusions can reasonably be drawn from their output, say Bill Kanasky and Steve Wood at Courtroom Sciences.

  • Attorneys Using AI May Have Ethical Duty To Redact Docs

    Author Photo

    The trajectory of legal ethics guidance in recent years strongly suggests that as redaction technology becomes more accessible, the failure to use it when uploading highly confidential materials into artificial intelligence tools will become increasingly difficult to defend as reasonable, say attorneys at Lewis Brisbois.

  • Cannabis, Psychedelics Boom Raises IP Hurdles

    Author Photo

    Recent data regarding patent filing activity and litigation in the cannabis and psychedelics markets indicates that as commercial interest accelerates, the scope of publicly accessible prior art is also expanding, setting a higher bar for novelty and nonobviousness in patent applications, say attorneys at Sterne Kessler.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.